TerminatedPhase 4ketamine

Anesthetic Techniques in EP Patients

Sponsored by University of California, Los Angeles

NCT ID
NCT02664922
Target Enrollment
35 participants
Start Date
2012-05
Est. Completion
2013-12

About This Study

The purpose of this study is to compare different combinations of anesthetic drugs (cause loss of sensation) in terms of effectiveness, adverse effects, pain relief, and patient comfort for cardiac electrophysiology procedures. In addition, the investigators are studying the different anesthetic combinations to determine the best approach in terms of identification and treatment of arrhythmias.

Conditions Studied

Cardiac Disease

Interventions

  • Propofol
  • Ketamine
  • Remifentanil
  • Sevoflurane

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients scheduled for cardiac electrophysiology procedures
* Patients ≥18 years of age

Exclusion Criteria:

* Gastroesophageal reflux disease (GERD),
* pulmonary hypertension,
* severe pulmonary disease,
* obstructive sleep apnea (OSA) with continuous positive airway pressure therapy (CPAP)

Study Locations (1)

Ronald Reagan UCLA Medical Center
Los Angeles, California, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source